Lancet Oncology, 1470-2045


View graph of relations

Related Publications
  1. Trastuzumab duocarmazine in locally advanced and metastatic solid tumours and HER2-expressing breast cancer: a phase 1 dose-escalation and dose-expansion study

    Banerji, U., van Herpen, C. M. L., Saura, C., Thistiethwaite, F., Lord, S., Moreno, V., Macpherson, I. R., Boni, V., Rolfo, C., de Vries, E. G. E., Rottey, S., Geenen, J., Eskens, F., Gil-Martin, M., Mommers, E. C., Koper, N. P. & Aftimos, P., Aug-2019, In : Lancet Oncology. 20, 8, p. 1124-1135 12 p.

    Research output: Contribution to journalArticleAcademicpeer-review

  2. Nivolumab plus ipilimumab versus sunitinib in first-line treatment for advanced renal cell carcinoma: extended follow-up of efficacy and safety results from a randomised, controlled, phase 3 trial

    CheckMate 214 investigators, Motzer, R. J., Rini, B. I., McDermott, D. F., Arén Frontera, O., Hammers, H. J., Carducci, M. A., Salman, P., Escudier, B., Beuselinck, B., Amin, A., Porta, C., George, S., Neiman, V., Bracarda, S., Tykodi, S. S., Barthélémy, P., Leibowitz-Amit, R., Plimack, E. R., Oosting, S. F., Redman, B., Melichar, B., Powles, T., Nathan, P., Oudard, S., Pook, D., Choueiri, T. K., Donskov, F., Grimm, M-O., Gurney, H., Heng, D. Y. C., Kollmannsberger, C. K., Harrison, M. R., Tomita, Y., Duran, I., Grünwald, V., McHenry, M. B., Mekan, S. & Tannir, N. M., 16-Aug-2019, In : Lancet Oncology. 16 p.

    Research output: Contribution to journalArticleAcademicpeer-review

  3. Adjuvant chemoradiotherapy versus radiotherapy alone in women with high-risk endometrial cancer (PORTEC-3): patterns of recurrence and post-hoc survival analysis of a randomised phase 3 trial

    PORTEC study group, de Boer, S. M., Powell, M. E., Mileshkin, L., Katsaros, D., Bessette, P., Haie-Meder, C., Ottevanger, P. B., Ledermann, J. A., Khaw, P., D'Amico, R., Fyles, A., Baron, M-H., Jürgenliemk-Schulz, I. M., Kitchener, H. C., Nijman, H. W., Wilson, G., Brooks, S., Gribaudo, S., Provencher, D., Hanzen, C., Kruitwagen, R. F., Smit, V. T. H. B. M., Singh, N., Do, V., Lissoni, A., Nout, R. A., Feeney, A., Verhoeven-Adema, K. W., Putter, H. & Creutzberg, C. L., 22-Jul-2019, In : Lancet Oncology. 13 p.

    Research output: Contribution to journalArticleAcademicpeer-review

  4. Gardner's syndrome (familial adenomatous polyposis): a cilia-related disorder

    Gómez García, E. B. & Knoers, N. V. A. M., Jul-2009, In : Lancet Oncology. 10, 7, p. 727-35 9 p.

    Research output: Contribution to journalReview articleAcademicpeer-review

  5. Use of the Child-Pugh score in anticancer drug dosing decision making: proceed with caution - Authors' reply

    Krens, S. D., Lassche, G., Jansman, F. G. A., Desar, I. M. E., Lankheet, N. A. G., Burger, D. M., van Herpen, C. M. L. & van Erp, N. P., Jun-2019, In : Lancet Oncology. 20, 6, 1 p., e290.

    Research output: Contribution to journalArticleAcademicpeer-review

View all (72) »

ID: 1566534